Peter Bisgaard - Net Worth and Insider Trading

Peter Bisgaard Net Worth

The estimated net worth of Peter Bisgaard is at least $718,726 dollars as of 2024-05-27. Peter Bisgaard is the Director of Eargo Inc and owns about 279,660 shares of Eargo Inc (EAR) stock worth over $718,726. Details can be seen in Peter Bisgaard's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Peter Bisgaard has not made any transactions after 2020-10-20 and currently still holds the listed stock(s).

Transaction Summary of Peter Bisgaard

Peter Bisgaard Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Peter Bisgaard owns 6 companies in total, including Eargo Inc (EAR) , Ra Pharmaceuticals Inc (RARX) , and HTG Molecular Diagnostics Inc (HTGMQ) among others .

Click here to see the complete history of Peter Bisgaard’s form 4 insider trades.

Insider Ownership Summary of Peter Bisgaard

Ticker	Comapny	Transaction Date	Type of Owner
EAR	Eargo Inc	2020-10-20	director
RARX	Ra Pharmaceuticals Inc	2018-06-28	director
HTGMQ	HTG Molecular Diagnostics Inc	2015-05-05	director
		2014-11-05	director
		2014-08-12	director
		2014-05-07	director

Peter Bisgaard Latest Holdings Summary

Peter Bisgaard currently owns a total of 1 stock. Peter Bisgaard owns 279,660 shares of Eargo Inc (EAR) as of October 20, 2020, with a value of $718,726.

Latest Holdings of Peter Bisgaard

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
EAR	Eargo Inc	2020-10-20	279,660	2.57	718,726

Holding Weightings of Peter Bisgaard

Peter Bisgaard Form 4 Trading Tracker

According to the SEC Form 4 filings, Peter Bisgaard has made a total of 1 transactions in Eargo Inc (EAR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Eargo Inc is the acquisition of 11,111 shares on October 20, 2020, which cost Peter Bisgaard around $4 Million.

Insider Trading History of Peter Bisgaard

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Peter Bisgaard Trading Performance

GuruFocus tracks the stock performance after each of Peter Bisgaard's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter Bisgaard is 64.84%. GuruFocus also compares Peter Bisgaard's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter Bisgaard within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Peter Bisgaard's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Peter Bisgaard

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	5.64
Relative Return to S&P 500(%)	2.32

Peter Bisgaard Ownership Network

Ownership Network List of Peter Bisgaard

No Data

Ownership Network Relation of Peter Bisgaard

Peter Bisgaard Owned Company Details

What does Eargo Inc do?

Who are the key executives at Eargo Inc?

Peter Bisgaard is the director of Eargo Inc. Other key executives at Eargo Inc include Chief Accounting Officer Mark Thorpe , Chief Operating Officer William Brownie , and Chief Financial Officer Adam Laponis .

Eargo Inc (EAR) Insider Trades Summary

Over the past 18 months, Peter Bisgaard made no insider transaction in Eargo Inc (EAR). Other recent insider transactions involving Eargo Inc (EAR) include a net sale of 1,528 shares made by William Brownie , a net sale of 38 shares made by Adam Laponis , and a net sale of 6 shares made by Mark Thorpe .

In summary, during the past 3 months, insiders sold 0 shares of Eargo Inc (EAR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,630 shares of Eargo Inc (EAR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,630 shares.

Eargo Inc (EAR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Eargo Inc Insider Transactions

No Available Data

What does Ra Pharmaceuticals Inc do?

Who are the key executives at Ra Pharmaceuticals Inc?

Peter Bisgaard is the director of Ra Pharmaceuticals Inc. Other key executives at Ra Pharmaceuticals Inc include Executive VP and CFO David Charles Lubner , director & 10 percent owner Rajeev M. Shah , and 10 percent owner New Enterprise Associates 13 Lp .

Ra Pharmaceuticals Inc (RARX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ra Pharmaceuticals Inc (RARX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ra Pharmaceuticals Inc (RARX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ra Pharmaceuticals Inc (RARX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ra Pharmaceuticals Inc Insider Transactions

No Available Data

What does HTG Molecular Diagnostics Inc do?

Who are the key executives at HTG Molecular Diagnostics Inc?

Peter Bisgaard is the director of HTG Molecular Diagnostics Inc. Other key executives at HTG Molecular Diagnostics Inc include Senior VP of Therapeutics Stephen Barat , 10 percent owner L5 Capital Inc. , and SVP/Chief Commercial Officer Byron Lawson .

HTG Molecular Diagnostics Inc (HTGMQ) Insider Trades Summary

Over the past 18 months, Peter Bisgaard made no insider transaction in HTG Molecular Diagnostics Inc (HTGMQ). Other recent insider transactions involving HTG Molecular Diagnostics Inc (HTGMQ) include a net sale of 888 shares made by Stephen Barat ,

In summary, during the past 3 months, insiders sold 0 shares of HTG Molecular Diagnostics Inc (HTGMQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 888 shares of HTG Molecular Diagnostics Inc (HTGMQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 888 shares.

HTG Molecular Diagnostics Inc (HTGMQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

HTG Molecular Diagnostics Inc Insider Transactions

No Available Data

What does Nevro Corp do?

Who are the key executives at Nevro Corp?

Peter Bisgaard is the director of Nevro Corp. Other key executives at Nevro Corp include Chief Commercial Officer Greg Siller , President & CEO Kevin R Thornal , and Chief Accounting Officer Richard B. Carter .

Nevro Corp (NVRO) Insider Trades Summary

Over the past 18 months, Peter Bisgaard made no insider transaction in Nevro Corp (NVRO). Other recent insider transactions involving Nevro Corp (NVRO) include a net purchase of 7,500 shares made by Shawn Mccormick ,

In summary, during the past 3 months, insiders sold 0 shares of Nevro Corp (NVRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nevro Corp (NVRO) were sold and 7,500 shares were bought by its insiders, resulting in a net purchase of 7,500 shares.

Nevro Corp (NVRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nevro Corp Insider Transactions

No Available Data

What does Otonomy Inc do?

Who are the key executives at Otonomy Inc?

Peter Bisgaard is the director of Otonomy Inc. Other key executives at Otonomy Inc include Chief Scientific Officer Alan Charles Foster , director & President & CEO David Allen Weber , and CFO/Ch. Business Offcr & Sec. Paul E Cayer .

Otonomy Inc (OTIC) Insider Trades Summary

Over the past 18 months, Peter Bisgaard made no insider transaction in Otonomy Inc (OTIC). Other recent insider transactions involving Otonomy Inc (OTIC) include a net sale of 42,242 shares made by Vickie L Capps ,

In summary, during the past 3 months, insiders sold 0 shares of Otonomy Inc (OTIC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 42,242 shares of Otonomy Inc (OTIC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 42,242 shares.

Otonomy Inc (OTIC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Otonomy Inc Insider Transactions

No Available Data

What does Alder BioPharmaceuticals Inc do?

Who are the key executives at Alder BioPharmaceuticals Inc?

Peter Bisgaard is the director of Alder BioPharmaceuticals Inc. Other key executives at Alder BioPharmaceuticals Inc include 10 percent owner H Lundbeck A S , Chief Medical Officer Paul Streck , and Chief Financial Officer Carlos Campoy .

Alder BioPharmaceuticals Inc (ALDR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Alder BioPharmaceuticals Inc (ALDR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alder BioPharmaceuticals Inc (ALDR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alder BioPharmaceuticals Inc (ALDR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Alder BioPharmaceuticals Inc Insider Transactions

No Available Data

Peter Bisgaard Mailing Address

Above is the net worth, insider trading, and ownership report for Peter Bisgaard. You might contact Peter Bisgaard via mailing address: 11804 North Creek Parkway South, Bothell Wa 98011.

Discussions on Peter Bisgaard

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.